MNK1 and MNK2 Regulation in HER2-overexpressing Breast Cancer Lines

Journal of Biological Chemistry- United States

doi 10.1074/jbc.m607368200

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Effectiveness of Neoadjuvant Trastuzumab and Chemotherapy in HER2-overexpressing Breast Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2013English

HER2/ErbB2 Activates HSF1 and Thereby Controls HSP90 Clients Including MIF in HER2-overexpressing Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2013English

Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Trastuzumab-Dm1: A Review of the Novel Immuno-Conjugate for HER2- Overexpressing Breast Cancer

The Open Breast Cancer Journal
2009English

Ultrasmall Targeted Nanoparticles With Engineered Antibody Fragments for Imaging Detection of HER2-overexpressing Breast Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Detection of an Elevated HER2 Expression in McF-7 Breast Cancer Cells Overexpressing Estrogen Receptor Β1

Oncology Reports
MedicineCancer ResearchOncology
2008English

Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells With Primary Trastuzumab Resistance

Anti-Cancer Agents in Medicinal Chemistry
Cancer ResearchMolecular MedicinePharmacology
2012English

Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy